AstraZeneca, UK’s second-biggest drug maker, has dragged Sun Pharmaceuticals to court in a bid to prevent the Indian company from selling a generic form of the ulcer medicine Nexium IV in the US before 2014.
Related posts:
- Satyam moves court against UK’s Upaid Mahindra Satyam has now dragged the British mobile and...
- Hero Honda offers 4000% dividend Country’s top bike maker Hero Honda on Tuesday declared a...
- AstraZeneca teams up with Torrent for 18 generic drugs Leading UK drugmaker AstraZeneca Plc will brand and market 18...
- Tata Tele brings new plan at Re 1 for 5 mins Tata Teleservices launched a new call plan that would charge...
- Small fields in KG-D6 unviable at $4.20: RIL After state-run ONGC, RIL has also said the present price...
Related posts brought to you by Yet Another Related Posts Plugin.
You must log in to post a comment.